Archives of disease in childhood. Fetal and neonatal edition
Value of targeted testing for cytomegalovirus in preterm infants: 7 years' experience at a tertiary London hospital.
Helen Payne, Rebecca Faber, Ravi D Mistry, Aaron Colin John Bell, Harry James, Malaz Elsaddig, Ana Silva Ferreira, Grace Li, Anjali Rampersad, Lidia Tyszczuk, Paul Randell, Elizabeth Whittaker, Hermione Lyall
Published: 202510.1136/archdischild-2025-329084
Abstract
BACKGROUND: Targeted testing for cytomegalovirus (CMV) in preterm infants <21 days has two benefits: timely congenital CMV (cCMV) diagnosis, and differentiation between cCMV and postnatal CMV (pCMV). We present an audit of targeted testing for cCMV a…
Preview only. Read the full abstract at the source